Further investigation into the exact mechanistic regulation of MMP28 by CD36 and MMP28’s interaction with E-cadherin is needed to potentially develop new, more effective treatment strategies for patients with late-stage CRC or other solid malignancies. This evidence concerns the gene CD36 and colorectal carcinoma.